Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-03-17Clinical Trial Update: Study CB-839 in Combination With Nivolumab in Patients With Melanoma, Clear Cell Renal Cell Carcinoma (ccRCC) and Non-Small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]
Clinical trial update for CB-839 in combination with nivolumab in melanoma, clear cell renal cell carcinoma, and non-small cell lung cancer …
-
CLINICAL_TRIALS trial_result · 2023-03-17Clinical Trial Update: Assessing an Oral EGFR Inhibitor,YK-209A in Patients Who Have Advanced Non-small Cell Lung Cancer With EGFR [Phase 1, Phase 2]
Clinical trial update for an oral EGFR inhibitor YK-209A in advanced non-small cell lung cancer (Phase 1/Phase 2) with unknown status.
-
CLINICAL_TRIALS trial_result · 2023-03-14Clinical Trial Update: Paclitaxel-bevacizumab in Advanced Lung Cancer [Phase 3]
Phase 3 clinical trial update for paclitaxel-bevacizumab in non-squamous non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-03-14Clinical Trial Update: Early or Delayed Intervention of Brain Radiotherapy Combined With Almonertinib in EGFR Mutated NSCLC With Brain Metastases [Phase 3]
Phase 3 trial investigating early or delayed brain radiotherapy combined with almonertinib in EGFR-mutated non-small cell lung cancer with b…
-
CLINICAL_TRIALS trial_result · 2023-03-14Clinical Trial Update: Maintenance After Induction Chemotherapy in Elderly Patients With Advanced Non-small Cell Lung Cancer [Phase 3]
Phase 3 trial evaluating maintenance therapy after induction chemotherapy in elderly patients with advanced non-small cell lung cancer has c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-03-14Clinical Trial Update: Chemotherapy for Lung Cancer in HIV-positive Patients [Phase 2]
A Phase 2 clinical trial assessing chemotherapy for non-small cell lung cancer in HIV-positive patients has completed.
-
CLINICAL_TRIALS trial_result · 2023-03-13Clinical Trial Update: A Dose Escalation and Cohort Expansion Study of NKTR-214 in Combination With Nivolumab and Other Anti-Cancer Therapies in Patients With Select Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial evaluating NKTR-214 in combination with nivolumab and other anti-cancer therapies in select advanced solid tumors completed …
-
CLINICAL_TRIALS trial_result · 2023-03-13Clinical Trial Update: Re-introduction of Pemetrexed and Cisplatin With Prolonged Angiogenic Blocking by Bevacizumab in Advanced Lung Cancer. [Phase 2]
Phase 2 trial updating re-introduction of pemetrexed and cisplatin with prolonged anti-angiogenic therapy using bevacizumab in metastatic no…
-
CLINICAL_TRIALS trial_result · 2023-03-09Clinical Trial Update: Bempegaldesleukin and Pembrolizumab With or Without Chemotherapy in Locally Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
Clinical trial update for bempegaldesleukin and pembrolizumab, with or without chemotherapy, in locally advanced or metastatic solid tumors;…
-
CLINICAL_TRIALS trial_result · 2023-03-08Clinical Trial Update: Immunological Variables Associated to ICI Toxicity in Cancer Patients [Phase 2]
A Phase 2 clinical trial investigating immunological variables associated with immune checkpoint inhibitor toxicity in cancer patients.
-
CLINICAL_TRIALS trial_result · 2023-03-06Clinical Trial Update: Camrelizumab Combined With Albumin-bound Paclitaxel and Platinum in Neoadjuvant Treatment of Resectable NSCLC [Phase 2]
A Phase 2 trial update evaluating camrelizumab with albumin-bound paclitaxel and platinum as neoadjuvant therapy for resectable non-small-ce…
-
CLINICAL_TRIALS trial_result · 2023-03-06Clinical Trial Update: Clinical Study of Ametinib Combined With Bevacizumab in First-line Treatment of Advanced NSCLC With EGFR-mutations. [Phase 2]
Phase 2 clinical trial updating the combination of ametinib and bevacizumab as first-line treatment for advanced non-small cell lung cancer …
-
CLINICAL_TRIALS trial_result · 2023-03-03Clinical Trial Update: A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors [Phase 1, Phase 2]
A Phase I/II study investigating regorafenib in combination with avelumab in various solid tumors, spanning Phase 1 and Phase 2 cohorts.
-
CLINICAL_TRIALS trial_result · 2023-03-01Clinical Trial Update: Nivolumab and Ipilimumab Versus Chimiotherapy in First Line Treatment in PS 2 or Elderly in Advanced NSCLC Patients [Phase 3]
A phase 3 trial comparing nivolumab plus ipilimumab versus chemotherapy as first-line treatment in PS 2 or elderly patients with advanced no…
-
CLINICAL_TRIALS trial_result · 2023-03-01Clinical Trial Update: Carboplatin Plus Pemetrexed Plus Atezolizumab Plus Bevacizumab in Chemotherapy and Immunotherapy-naïve Patients With Stage IV Non-squamous Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating carboplatin, pemetrexed, atezolizumab, and bevacizumab in chemotherapy- and immunotherapy-naïve patients with stage…
-
CLINICAL_TRIALS trial_result · 2023-03-01Clinical Trial Update: EBUS-Miniforceps Biopsy Specimen Acquisition for PD-L1 Testing in Nonsmall Cell Lung Cancer [NA]
A completed clinical trial evaluating EBUS miniforceps biopsy specimens for PD-L1 testing in non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2023-02-28Clinical Trial Update: Arginase-1 Peptide Vaccine in Patients With Metastatic Solid Tumors [Phase 1]
Phase 1 trial update on an arginase-1 peptide vaccine in patients with metastatic solid tumors, including non-small cell lung cancer and uro…
-
CLINICAL_TRIALS trial_result · 2023-02-24Clinical Trial Update: A Phase II Study of Rulonilimab Combined With Chemotherapy in the First-Line Treatment for Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase II study evaluating rulonilimab in combination with chemotherapy as first-line treatment for advanced or metastatic non-small cell lun…
-
CLINICAL_TRIALS trial_result · 2023-02-23Clinical Trial Update: Hyperpolarized Xenon Gas MR Imaging in NSCLC Radiotherapy [Phase 2]
Phase 2 clinical trial update on hyperpolarized xenon gas MRI imaging for radiotherapy planning/assessment in non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2023-02-22Clinical Trial Update: Adebrelimab Combined With Bevacizumab and Albumin Paclitaxel in Non-squamous NSCLC After First-line Treatment [Phase 2]
Phase 2 trial update evaluating Adebrelimab with bevacizumab and albumin paclitaxel in non-squamous non-small cell lung cancer after first-l…
-
CLINICAL_TRIALS trial_result · 2023-02-21Clinical Trial Update: Local Ablative Stereotactic Radiotherapy for Residual Hypermetabolic Lesion in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Long-term Responders to Immunotherapy [Phase 3]
Phase 3 trial evaluating local ablative stereotactic radiotherapy for residual hypermetabolic lesions in locally advanced or metastatic non-…
-
CLINICAL_TRIALS trial_result · 2023-02-21Clinical Trial Update: Best EGFR-TKI Sequence in NSCLC Harboring EGFR Mutations [Phase 2]
Phase 2 clinical trial evaluating the best sequence of EGFR-TKI therapy in NSCLC with EGFR mutations; status not provided.
-
CLINICAL_TRIALS trial_result · 2023-02-15Clinical Trial Update: Radiation and Chemotherapy With Ipilimumab Followed by Nivolumab for Patients With Stage III Unresectable Non-Small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]
Phase 1/2 trial evaluating radiation and chemotherapy with ipilimumab followed by nivolumab in stage III unresectable non-small cell lung ca…
-
CLINICAL_TRIALS trial_result · 2023-02-14Clinical Trial Update: TQB2450 Injection Combined With Chemotherapy Followed by Sequential Combination With Anlotinib Hydrochloride Capsule for First-line Treatment of Advanced Squamous Non-small Cell Lung Cancer. [Phase 3]
Phase 3 trial evaluating TQB2450 with chemotherapy followed by anlotinib for first-line treatment of advanced squamous non-small cell lung c…
-
CLINICAL_TRIALS trial_result · 2023-02-14Clinical Trial Update: Phase I/II Study of SY-3505 in Patients With ALK-positive Advanced Non-small Cell Lung Cancer [Phase 1, Phase 2]
A Phase I/II clinical trial update for SY-3505 in ALK-positive advanced non-small cell lung cancer is ongoing, with status currently unknown…